Dr. Mark Geyer, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Acute Lymphoblastic Leukemia
Mark Geyer, MD has run 2 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Philadelphia Chromosome Positive
Mark Geyer, MD has run 1 trial for Philadelphia Chromosome Positive. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering At Basking Ridge (Limited Protocol Activities)
Clinical Trials Mark Geyer, MD is currently running
CAR T Cell Therapy
for Acute Myeloid Leukemia
This trial is testing the safety of using specially modified immune cells to treat cancer patients who haven't responded to other treatments. The goal is to find the highest dose that causes few or mild side effects.
Recruiting
1 award
Phase 1
41 criteria
Radioimmunotherapy + CAR T-cell Therapy
for Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
This is a pilot study; patients will receive 131-I apamistamab prior to CAR T-cell infusion in order to determine the maximum tolerated dose of 131-I apamistamab is exceeded at 75 mCi, and if so, to assess the safety of a step-down dose of 50 mCi.
Recruiting
1 award
Phase < 1
26 criteria
More about Mark Geyer, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Mark Geyer, MD has experience with
- Blinatumomab
- Dasatinib
- CD371-YSNVZ-IL18 CAR T Cells
- 131-I Apamistamab
- CAR T-cell
Breakdown of trials Mark Geyer, MD has run
Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Geyer, MD specialize in?
Mark Geyer, MD focuses on Acute Lymphoblastic Leukemia and Philadelphia Chromosome Positive. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are BCR-ABL1 positive.
Is Mark Geyer, MD currently recruiting for clinical trials?
Yes, Mark Geyer, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Mark Geyer, MD has studied deeply?
Yes, Mark Geyer, MD has studied treatments such as Blinatumomab, Dasatinib, CD371-YSNVZ-IL18 CAR T cells.
What is the best way to schedule an appointment with Mark Geyer, MD?
Apply for one of the trials that Mark Geyer, MD is conducting.
What is the office address of Mark Geyer, MD?
The office of Mark Geyer, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.